Sanovas Inc., a life science holding company that is accelerating the development and commercialization of next-generation micro-invasive diagnostics, devices and drug delivery technologies, through its spin-off companies, has raised $30+ million to fund its operations, 2/3 of which has come from a pioneering funding model conceived... Read More
The post Brief: Sanovas “Social Finance” & Asset Diversification Model Boosts Valuation from $60 million to $710 million appeared first on Crowdfund Insider.